Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederroche.com
Roche Media News
Get the latest updates from Roche Media News directly as they happen.
Follow now 184 followers
Latest posts
Last updated 4 days ago
Roche introduces innovative Elecsys PRO-C3 test to improve precision in evaluating liver fibrosis severity
4 days ago
Elecsys PRO-C3, used with the ADAPT formula (age, diabetes status, PRO-C3, platelets)...
CHMP recommends EU label update for Roche’s Phesgo to allow administration outside of clinical settings
10 days ago
Positive recommendation based on clinical, real-world and bioequivalence data supporting feasibility and...
Roche granted FDA Breakthrough Device Designation for first AI-driven companion diagnostic for non-small cell lung cancer
11 days ago
The VENTANA TROP2 (EPR20043) RxDx Device is an immunohistochemistry (IHC) assay combined...
New England Journal of Medicine publishes phase III data showing single-dose Xofluza significantly reduces influenza virus transmission
15 days ago
Detailed results from the CENTERSTONE trial show treatment with Xofluza reduced the...
[Ad hoc announcement pursuant to Art. 53 LR] Roche continues good momentum into 2025 with 6% (CER) sales growth in the first quarter
16 days ago
Group sales grew by 6%1 at constant exchange rates (CER; 7% in...
Roche receives CE Mark for its Chest Pain Triage algorithm to enhance detection of Acute Coronary Syndrome (ACS)
17 days ago
Roche, in collaboration with Universitätsklinikum Heidelberg, has developed a Chest Pain Triage...
Roche to invest USD 50 billion in pharmaceuticals and diagnostics in the United States over the next five years
18 days ago
USD 50 billion commitment includes new state-of-the art research and development (R&D)...
European Commission approves Roche’s Columvi as the first bispecific antibody for diffuse large B-cell lymphoma after initial therapy
26 days ago
Approval based on Phase III STARGLO study where Columvi in combination with...
Roche presents novel therapeutic and diagnostic advancements in Alzheimer’s at AD/PD 2025
about 1 month ago
New trontinemab data continue to support rapid and deep, dose-dependent reduction of...
Roche provides update on Phase III OCREVUS high dose study in people with relapsing multiple sclerosis
about 1 month ago
MUSETTE trial was designed to determine whether a higher dose of the...
Roche Annual General Meeting 2025
about 2 months ago
Shareholders approved all proposals of the Board of Directors Severin Schwan was...
Roche to share latest scientific advancements from its neuromuscular portfolio at Muscular Dystrophy Association (MDA) 2025 conference
about 2 months ago
New Evrysdi five-year data from the SUNFISH study showed continued stabilisation of...